Brazil Transplantation Market Size & Outlook, 2023-2030
Brazil transplantation market, 2018-2030 (US$M)
Related Markets
Brazil transplantation market highlights
- The Brazil transplantation market generated a revenue of USD 275.1 million in 2023 and is expected to reach USD 510.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
- In terms of segment, tissue products was the largest revenue generating product in 2023.
- Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Transplantation market data book summary
| Market revenue in 2023 | USD 275.1 million |
| Market revenue in 2030 | USD 510.7 million |
| Growth rate | 9.2% (CAGR from 2023 to 2030) |
| Largest segment | Tissue products |
| Fastest growing segment | Immunosuppressive Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
| Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.7% of the global transplantation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil transplantation market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 465.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transplantation Market Scope
Transplantation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil transplantation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 57.03% in 2023. Horizon Databook has segmented the Brazil transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounts for a major market share, as the country has the largest healthcare market in Latin America, which spent 9.2% of its GDP on healthcare in 2017. Brazil has a Unified Health System (SUS), a single-payer public health network that provides free medical services to all Brazilians, where about 95% of the transplants are managed by the SUS.
According to the Health Ministry, Brazil has the second-highest number of transplant procedures in the world, followed by the U.S. Moreover, medical tourism in the country is among the fastest-growing medical treatment hotspots for international patients seeking affordable treatment.
Intensive research carried by the organizations to reduce organ transplant waiting time is a breakthrough in the transplantation market. In February 2019, the University of São Paulo's Biosciences Institute (IB-USP) and the Human Genome and Stem-Cell Research Center (HUG-CELL) initiated the cross-species transplantation project.
Reasons to subscribe to Brazil transplantation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil transplantation market databook
-
Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil transplantation market , including forecasts for subscribers. This country databook contains high-level insights into Brazil transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil transplantation market size, by product, 2018-2030 (US$M)
Brazil Transplantation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
